Viridian Therapeutics Inc (VRDN)

Nov 02, 2025

Trend analysis for Viridian Therapeutics Inc. this weekQuarterly Risk Review & High Win Rate Trade Alerts - newser.com

Nov 02, 2025

Nov 02, 2025

Smart tools for monitoring Viridian Therapeutics Inc.’s price actionJuly 2025 PreEarnings & Real-Time Volume Surge Alerts - newser.com

Nov 02, 2025

Nov 02, 2025

Can Viridian Therapeutics Inc. stock attract ESG capital inflowsMarket Rally & Scalable Portfolio Growth Methods - newser.com

Nov 02, 2025

Nov 02, 2025

Top chart patterns to watch in Viridian Therapeutics Inc.Bull Run & Weekly High Momentum Picks - newser.com

Nov 02, 2025

Nov 02, 2025

How hedge fund analytics apply to Viridian Therapeutics Inc. stockTrade Exit Report & Comprehensive Market Scan Insights - newser.com

Nov 02, 2025

Nov 02, 2025

Why Viridian Therapeutics Inc. (1S1) stock is a must watch tickerWeekly Stock Analysis & Verified Chart Pattern Signals - newser.com

Nov 02, 2025

Nov 01, 2025

Regression analysis insights on Viridian Therapeutics Inc. performanceDay Trade & Free Verified High Yield Trade Plans - newser.com

Nov 01, 2025

Nov 01, 2025

Is Viridian Therapeutics Inc. stock attractive for growth ETFsSell Signal & Community Consensus Trade Alerts - newser.com

Nov 01, 2025

Nov 01, 2025

Chart based analysis of Viridian Therapeutics Inc. trendsJuly 2025 Retail & AI Forecasted Entry and Exit Points - newser.com

Nov 01, 2025

Nov 01, 2025

Can swing trading help recover from Viridian Therapeutics Inc. lossesMarket Rally & Advanced Technical Signal Analysis - newser.com

Nov 01, 2025

Nov 01, 2025

Oppenheimer Maintains Viridian Therapeutics (VRDN) Outperform Recommendation - MSN

Nov 01, 2025

Nov 01, 2025

How Viridian Therapeutics Inc. stock reacts to job market dataEarnings Growth Summary & Free Community Supported Trade Ideas - newser.com

Nov 01, 2025

Nov 01, 2025

Will Viridian Therapeutics Inc. (1S1) stock attract long term capital inflowsCPI Data & Accurate Entry and Exit Point Alerts - newser.com

Nov 01, 2025

Nov 01, 2025

Moody Aldrich Partners LLC Has $1.25 Million Stake in Viridian Therapeutics, Inc. $VRDN - MarketBeat

Nov 01, 2025

Oct 31, 2025

Reassessing Viridian Therapeutics (VRDN) Valuation Following Insider Buying and Progress in Thyroid Eye Disease Program - Sahm

Oct 31, 2025

Oct 31, 2025

Astria, Viridian Therapeutics, and More Stocks See Action From Activist Investors - Barron's

Oct 31, 2025

Oct 31, 2025

Fairmount Funds Management LLC's Strategic Acquisition in Viridi - GuruFocus

Oct 31, 2025

Oct 31, 2025

Wedbush Reduces Earnings Estimates for Viridian Therapeutics - MarketBeat

Oct 31, 2025

Oct 31, 2025

Can machine learning forecast Viridian Therapeutics Inc. recoveryGold Moves & Fast Entry Momentum Trade Alerts - newser.com

Oct 31, 2025

Oct 31, 2025

How supply chain issues affect Viridian Therapeutics Inc. stock2025 Top Decliners & Free High Return Stock Watch Alerts - newser.com

Oct 31, 2025

Oct 31, 2025

How Viridian Therapeutics Inc. stock performs in interest rate cyclesEarnings Miss & Consistent Growth Stock Picks - newser.com

Oct 31, 2025

Oct 31, 2025

Is Viridian Therapeutics Inc. (1S1) stock a buy on weaknessTrade Volume Report & Real-Time Volume Surge Alerts - newser.com

Oct 31, 2025

Oct 31, 2025

Using Ichimoku Cloud for Viridian Therapeutics Inc. technicalsEarnings Overview Report & Short-Term High Return Ideas - newser.com

Oct 31, 2025

Oct 31, 2025

How buybacks impact Viridian Therapeutics Inc. stock value2025 Top Gainers & Technical Confirmation Trade Alerts - newser.com

Oct 31, 2025

Oct 30, 2025

Wedbush Expects Reduced Earnings for Viridian Therapeutics - MarketBeat

Oct 30, 2025

Oct 30, 2025

Can Viridian Therapeutics Inc. (1S1) stock survive global slowdownWeekly Trend Report & Fast Moving Market Watchlists - newser.com

Oct 30, 2025

Oct 30, 2025

Published on: 2025-10-30 01:27:01 - newser.com

Oct 30, 2025

Oct 29, 2025

Published on: 2025-10-29 21:18:30 - newser.com

Oct 29, 2025

Oct 29, 2025

Is Viridian Therapeutics Inc. stock attractive for ETFsOptions Play & Weekly Setup with ROI Potential - Fundação Cultural do Pará

Oct 29, 2025

Oct 29, 2025

Is Viridian Therapeutics Inc. stock a smart buy before Fed meetingQuarterly Profit Review & Daily Growth Stock Investment Tips - newser.com

Oct 29, 2025